4D Molecular Therapeutics Shares Are Trading Lower After Chardan Capital Cut Its Price Target on the Stock From $39 to $30.

BenzingaFeb 11 15:08 ET

Express News | 4D Molecular Therapeutics Shares Are Trading Lower After Chardan Capital Cut Its Price Target on the Stock From $39 to $30

BenzingaFeb 11 15:08 ET

A Quick Look at Today's Ratings for 4D Molecular Therapeutics(FDMT.US), With a Forecast Between $30 to $42

Moomoo NewsFeb 11 08:00 ET · Ratings

Analysts' Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and 4D Molecular Therapeutics (FDMT)

TipRanksFeb 11 06:10 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Immunovant (IMVT) and 4D Molecular Therapeutics (FDMT)

TipRanksFeb 11 05:11 ET · Ratings

Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study

BenzingaFeb 10 10:26 ET